PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
Here’s the latest on how there is a shift in psychiatry toward a new way of thinking about depression, its causes, and therapies.
The profession’s long embrace of the “monoamine hypothesis” — the idea that depression primarily results from abnormal levels of neurotransmitter chemicals in the brain and that drugs can restore the proper balance — is giving way to a more complex understanding and alternative treatments, from ketamine to psychedelics to magnetic stimulation.
Read more“Tragic optimism” is the search for meaning during the inevitable tragedies of human existence, and is better for us than avoiding darkness and trying to “stay positive.”
Read moreWhat does God, quantum mechanics and consciousness have in common?
Theories that try to explain these big metaphysical mysteries fall short, making agnosticism the only sensible stance, this author writes.
What do you think?
Read moreIn a new “astromycological” venture launched in conjunction with NASA, mycologist Paul Stamets and various research teams are studying how fungi can be leveraged to build extraterrestrial habitats and perhaps someday even terraform planets.
Read moreKratom is used as an alternative to opioids, most commonly to treat pain or as a substitute for street drugs. The herb, formally known as Mitrogyna speciosa, has a centuries-long history of use in herbal medicine in Southeast Asia—notably as a substitute for opium.
Read moreThe film Fantastic Fungi is now available on Netflix… check it out!
Read moreCheck out this nifty guide for safety with ayahuasca, for practitioners and participants.
Read moreThis study shows that many psychedelic users turn to storytelling to reframe challenging trips into positive experiences.
Read moreThis beautiful short film is about life lessons from an 88-year-old woman.
An intimate and artful slice-of-life portrait, Inga captures the routines and reflections of an 88-year-old woman named Inga Boysen.
Read moreRecently, psychedelic drugs have once again taken popular culture by storm.
From the psychedelic startup companies newly forming on Wall Street to a recent New York Timesarticle that claims "psychedelic drugs are closer to medicinal use," it seems that there is a renewed media and medical interest in acid (LSD), mushrooms (psilocybin), ecstasy (MDMA), ayahuasca, DMT (dimethyltryptamine), and ketamine.
Read moreCheck out this podcast— Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies Rick Doblin discusses the role of MDMA-guided psychotherapy in treating PTSD.
Rick shares the story of how he developed a passion for healing the brain with psychedelics and the 35-year journey he’s endured to build a growing non-profit organization. He also explains how to effectively work with drugs that have been aggressively stigmatized and politicized.
Read more